Clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis
The introduction of nucleic acid amplification technology (NAT) for the detection of hepatitis C virus RNA in p lasma pools (addendum to note for guidance on plasma-derived medic inal products)